Why doctors still use antibiotics to treat Small Intestinal Bacterial Overgrowth
Explore why clinicians still rely on antibiotics like tetracycline and rifaximin for SIBO when the evidence and the patient picture support it.
Read articleAntibiotic literacy
Straight talk on antibiotic classes, when treatment is warranted, and how clinicians think about bacterial infections—not hype, not scare tactics.
Start reading
Clinical context
Bacterial overgrowth and confirmed infections are different from everyday stomach upset. Articles here explain how clinicians decide when a drug like tetracycline or rifaximin belongs in a plan—and when it does not.
Stewardship
Awareness means knowing that antibiotics target bacteria, not viruses, and that unnecessary courses can blunt future options. We break down common scenarios so the “when” is as clear as the “what.”

Reading paths
Jump into SIBO treatment rationale, antibiotic timing, or a plain-language tetracycline primer.
Why doctors still reach for antibiotics when treating small intestinal bacterial overgrowth.
When bacterial infections require treatment—and when waiting or another approach is wiser.
A simple guide to what tetracycline is and how this antibiotic class fits modern care.
An antibiotic is a tool with a specific job—not a default for every symptom.
Journal
Guides on antibiotic classes, awareness, and gut-focused treatment decisions.
Explore why clinicians still rely on antibiotics like tetracycline and rifaximin for SIBO when the evidence and the patient picture support it.
Read article
Antibiotics are powerful—and not always necessary. Learn the signals that point to a bacterial infection that needs treatment.
Read article
A plain-language look at tetracycline, the broader class it belongs to, and why awareness still matters decades on.
Read articleFAQ
No. Tetracycline is one drug within a larger class. Different antibiotics cover different bacteria and have different dosing, side-effect, and resistance profiles.
When testing and symptoms support bacterial overgrowth and non-drug measures are not enough. Choice of agent depends on the clinical picture—not a one-size default.
No. Content is educational. Treatment decisions belong with a qualified clinician who knows your history and labs.
Use the contact form. We read every message.